Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8373)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2016 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang J, Yu YL, Jin Y, Zhang Y, Zheng CQ. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis. World J Gastroenterol 2016; 22(33): 7579-7586 [PMID: 27672278 DOI: 10.3748/wjg.v22.i33.7579] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i33/7579.htm |
| Number | Citing Articles |
| 1 |
Xin Yu, Ying Chen, Lele Cui, Kaming Yang, Xumeng Wang, Linyuan Lei, Yanping Zhang, Xinyi Kong, Wanwen Lao, Zhenlin Li, Yang Liu, Yuetong Li, Changlong Bi, Chao Wu, Aixia Zhai. CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1052917
|
| 2 |
Rolf Teschke, Gaby Danan. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use. International Journal of Molecular Sciences 2023; 24(13): 10855 doi: 10.3390/ijms241310855
|
| 3 |
Rolf Teschke, Gaby Danan. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis. Medicines 2020; 7(10): 62 doi: 10.3390/medicines7100062
|
| 4 |
Melissa Palmer, Arie Regev, Keith Lindor, Mark I. Avigan, Lara Dimick‐Santos, William Treem, John F. Marcinak, James H. Lewis, Frank A. Anania, Daniel Seekins, Benjamin L. Shneider, Naga Chalasani. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics 2020; 51(1): 90 doi: 10.1111/apt.15579
|
| 5 |
Sabine Weber, Andreas Benesic, Marie-Luise Buchholtz, Isabelle Rotter, Alexander L. Gerbes. Antimitochondrial Rather than Antinuclear Antibodies Correlate with Severe Drug-Induced Liver Injury. Digestive Diseases 2021; 39(3): 275 doi: 10.1159/000511635
|
| 6 |
Qingling Xu, Weijia Zhu, Yufeng Yin. Diagnostic value of anti-mitochondrial antibody in patients with primary biliary cholangitis: A systemic review and meta-analysis. Medicine 2023; 102(45): e36039 doi: 10.1097/MD.0000000000036039
|
| 7 |
Shizuka Okazaki, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda. A Case of Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome during Treatment with Brodalumab for Generalized Pustular Psoriasis. Journal of Nippon Medical School 2021; 88(6): 569 doi: 10.1272/jnms.JNMS.2021_88-517
|
| 8 |
Wen Li, Fang Yuan, Lai-You Wang. Mechanism, prevention, and treatment of drug-induced cholestasis. World Chinese Journal of Digestology 2019; 27(21): 1295 doi: 10.11569/wcjd.v27.i21.1295
|
| 9 |
Guoxin Xu, Yanping Gong, Fenying Lu, Bin Wang, Zaixing Yang, Long Chen, Jingyu Min, Cuie Cheng, Tingwang Jiang. Endothelin receptor B enhances liver injury and pro-inflammatory responses by increasing G-protein-coupled receptor kinase-2 expression in primary biliary cholangitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21816-x
|
| 10 |
Rolf Teschke. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00730
|
| 11 |
S. Zandanell, M. Strasser, A. Feldman, J. Tevini, G. Strebinger, D. Niederseer, G. Pohla‐Gubo, U. Huber‐Schönauer, S. Ruhaltinger, B. Paulweber, C. Datz, T.K. Felder, E. Aigner. Low rate of new‐onset primary biliary cholangitis in a cohort of anti‐mitochondrial antibody‐positive subjects over six years of follow‐up. Journal of Internal Medicine 2020; 287(4): 395 doi: 10.1111/joim.13005
|
| 12 |
Weijia Duan, Sha Chen, Shuxiang Li, Tingting Lv, Buer Li, Xiaoming Wang, Yu Wang, Xinyan Zhao, Hong Ma, Xiaojuan Ou, Hong You, Jidong Jia. The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti‐mitochondrial antibodies but without baseline PBC. Hepatology Communications 2022; 6(11): 3112 doi: 10.1002/hep4.2067
|